Terpene conjugates of diaminedichloridoplatinum(II) complexes: Antiproliferative effects in HL-60 leukemia, 518A2 melanoma, and HT-29 colon cancer cells

被引:15
作者
Bernhardt, Guenther [2 ]
Biersack, Bernhard [1 ]
Bollwein, Susanne [2 ]
Schobert, Rainer [1 ]
Zoldakova, Miroslava [1 ]
机构
[1] Univ Bayreuth, Organ Chem Lab, D-95447 Bayreuth, Germany
[2] Univ Regensburg, Inst Pharm, D-93053 Regensburg, Germany
关键词
D O I
10.1002/cbdv.200890152
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Twenty-eight [6-(aminomethyl)nicotinate]dichloridoplatinum (II) complexes 1 esterified with various terpene alcohols either directly or via alkyl spacers were tested for antiproliferative activity in human 518A2 melanoma and HL-60 leukemia cells. Generally, conjugates with menthanes and polycyclic sesquiterpenes attached via propane-1,2-diyl spacers were most active. In the melanoma cells, the propane-12-diyl-spacered conjugates of (-)-menthol (1a(2')), (+)-neomenthol (1b(2')), (-)-carvomenthol (1h(2')), and (-)-isolongifolol (1n(2')) displayed growth inhibition at IC(50 <)4 mu M which is ten times smaller than that of cisplatin. The stationary diamino ligand was also crucial. The (-)-menthyl ester complexes with 23-diaminopropanoate (9a) and 2.4-diaminobutanoate (10a) ligands caused a greater and persistent growth inhibition in HT-29 colon cancer Cells upon long-term exposure when compared to the 6-(aminomethyl)nicotinate analogue 1a. The cedrenyl ester II and the menthoxyisopropyl ester 1a(2') proved most efficacious in all three tumor cell lines. The DNA binding of complexes 1 was assessed by electrophoretic band-shift experiments and found correlated to the terpene structure but not to the observed antiproliferative activities.
引用
收藏
页码:1645 / 1659
页数:15
相关论文
共 27 条
  • [1] STANDARDIZED KINETIC MICROASSAY TO QUANTIFY DIFFERENTIAL CHEMOSENSITIVITY ON THE BASIS OF PROLIFERATIVE ACTIVITY
    BERNHARDT, G
    REILE, H
    BIRNBOCK, H
    SPRUSS, T
    SCHOENENBERGER, H
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1992, 118 (01) : 35 - 43
  • [2] Synthesis, characterization and binding with DNA of four planaramineplatinum(II) complexes of the forms:: trans-PtL2Cl2 and [PtL3Cl]Cl, where L=3-hydroxypyridine, 4-hydroxypyridine and imidazo(1,2-α)pyridine
    Chowdhury, MA
    Huq, F
    Abdullah, A
    Beale, P
    Fisher, K
    [J]. JOURNAL OF INORGANIC BIOCHEMISTRY, 2005, 99 (05) : 1098 - 1112
  • [3] Synthesis of 17β-estradiol platinum(II) complexes:: Biological evaluation on breast cancer cell
    Descôteaux, C
    Provencher-Mandeville, J
    Mathieu, I
    Perron, V
    Mandal, SK
    Asselin, É
    Bérubé, G
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (22) : 3927 - 3931
  • [4] PREPARATION, CHARACTERIZATION, AND ANTICANCER ACTIVITY OF A SERIES OF CIS-PTCL2 COMPLEXES LINKED TO ANTHRAQUINONE INTERCALATORS
    GIBSON, D
    GEAN, KF
    BENSHOSHAN, R
    RAMU, A
    RINGEL, I
    KATZHENDLER, J
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (01) : 414 - 420
  • [5] Inhibition of protein prenylation by metabolites of limonene
    Hardcastle, IR
    Rowlands, MG
    Barber, AM
    Grimshaw, RM
    Mohan, MK
    Nutley, BP
    Jarman, M
    [J]. BIOCHEMICAL PHARMACOLOGY, 1999, 57 (07) : 801 - 809
  • [6] Monoterpene regulation of Ras and Ras-related protein expression
    Holstein, SA
    Hohl, RJ
    [J]. JOURNAL OF LIPID RESEARCH, 2003, 44 (06) : 1209 - 1215
  • [7] Tumour-inhibiting platinum complexes-state of the art and future perspectives
    Jakupec, MA
    Galanski, M
    Keppler, BK
    [J]. REVIEWS OF PHYSIOLOGY, BIOCHEMISTRY AND PHARMACOLOGY, VOL 146, 2003, 146 : 1 - 53
  • [8] Structure, recognition, and processing of cisplatin-DNA adducts
    Jamieson, ER
    Lippard, SJ
    [J]. CHEMICAL REVIEWS, 1999, 99 (09) : 2467 - 2498
  • [9] Chemosensitisation of malignant melanoma by BCL2 antisense therapy
    Jansen, B
    Wacheck, V
    Heere-Ress, E
    Schlagbauer-Wadl, H
    Hoeller, C
    Lucas, T
    Hoermann, M
    Hollenstein, U
    Wolff, K
    Pehamberger, H
    [J]. LANCET, 2000, 356 (9243) : 1728 - 1733
  • [10] Pharmacology of oxaliplatin and the use of pharmacogenomics to individualize therapy
    Kweekel, DM
    Gelderblom, H
    Guchelaar, HJ
    [J]. CANCER TREATMENT REVIEWS, 2005, 31 (02) : 90 - 105